Related Experiment Videos
Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium
R J Stewart1, B Chen, D Dowlatshahi
1Mood Disorders Program, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
Abstract:
There is an established relationship between the monoaminergic neurotransmitter system and mood disorders. In an attempt to define further the pathophysiology of mood disorders, research is focussing on intracellular second messenger systems, including cyclic adenosine 3',5'-monophosphate (cAMP) and the polyphosphoinositol generated second messengers. The availability of tissue from the Stanley Foundation Neuropathology Consortium has offered us the opportunity to make a number of observations with respect to these second messenger systems in tissue from patients with major depressive disorder and bipolar affective disorder. There is evidence that antidepressants stimulate components of the cAMP pathway in patients with depression while mood stabilizers blunt the same pathway in patients with bipolar disorder. Furthermore, downstream targets of this pathway appear to be altered in patients with mood disorders. The relations between changes in second messenger systems, gene transcription, and clinical effects of current therapeutic regimens has implications for development of novel treatments of mood disorders.
Insights
This study investigated intracellular signaling pathways in mood disorders. Antidepressants activate cyclic adenosine 3
Area of Science:
- Neuroscience
- Molecular Psychiatry
- Biochemistry
Background:
- Mood disorders are linked to the monoaminergic system.
- Intracellular second messenger systems are implicated in mood disorder pathophysiology.
- Research is exploring cyclic adenosine 3',5'-monophosphate (cAMP) and polyphosphoinositol pathways.
Purpose of the Study:
- To investigate second messenger systems in major depressive disorder and bipolar affective disorder.
- To examine the effects of antidepressants and mood stabilizers on these pathways.
- To understand the relationship between signaling pathways, gene transcription, and treatment response.
Main Methods:
- Utilized post-mortem brain tissue from the Stanley Foundation Neuropathology Consortium.
- Analyzed components of the cAMP pathway.
- Examined downstream targets of intracellular signaling.
Main Results:
- Antidepressants appear to stimulate cAMP pathway components in depression.
- Mood stabilizers seem to blunt the cAMP pathway in bipolar disorder.
- Alterations in downstream targets of the cAMP pathway are observed in mood disorders.
Conclusions:
- Findings suggest distinct roles for the cAMP pathway in depression and bipolar disorder.
- Understanding these pathways may lead to novel therapeutic strategies for mood disorders.
- The interplay between second messengers, gene expression, and treatment efficacy is crucial for future drug development.